Endovascular Engineering

Advanced thrombectomy solutions

Series C+
Menlo Park, CA
Founded 2020
Website

About

Endovascular Engineering is a medical technology startup specializing in advanced thrombectomy devices designed to remove blood clots and improve clinical outcomes in venous thromboembolism treatment. Founded around 2020, the company develops minimally invasive vascular intervention tools that enhance procedural efficiency and patient outcomes. It operates on a venture-funded model, having progressed through multiple funding rounds including a $42M Series B in early 2025. Its products target hospitals and vascular specialists working in critical care environments.

Products

  • Thrombectomy System — Device system designed to safely and efficiently remove blood clots in venous thromboembolism cases.
    Customer sectors: Healthcare providers, Hospitals, Vascular specialists

Company Details

Sector Deep Tech
Category Biotech & Therapeutics
Stage Series C+
Total Funding $57.0M
Employees 51-200
Last Funded April 7, 2026
Last Round $80.0M

Market research & competitive positioning

Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Endovascular Engineering — available to members.

Create a free account Sign in